Home » Topics » BioWorld Science

BioWorld Science
RSS

Antifungal activity and good tolerability in phase I trial of L-743872

May 24, 1996

Abelcet approved for marketing in Portugal

May 24, 1996

Antifungal antibiotic YM-47522 isolated by Yamanouchi

May 24, 1996

Amlexanox approvable in U.S.

May 24, 1996

L-749345 in clinical trials at Merck & Co.

May 24, 1996

Propecia NDA filing slated for late 1996

May 24, 1996

Ultiva okayed for marketing in Germany; U.S. approval recommended by committee

May 24, 1996

Wound-healing peptides claimed by Morinaga Milk

May 24, 1996

Rizatriptan NDA filing expected in mid-1997

May 24, 1996

L-742694: Morpholine-based NK1 antagonist

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...